MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (4)
2021
-
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
Leukemia, Vol. 35, Núm. 8, pp. 2358-2370
2011
-
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
Blood, Vol. 117, Núm. 6, pp. 1799-1805
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 475, Núm. 7354, pp. 101-105
2004
-
Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial
Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092